Liang Zou
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of the Safety, Tolerability and Preliminary Efficacy of CD19/BCMA-targeted CAR-T Therapy in Refractory Autoimmune Diseases (NCT07490951) | Liang Zou | 2026-03-22 |
Track Liang Zou automatically
Every clearance here is in the API, with alerts when new ones post.